参考文献/References:
[1]Fischer A,du Bois R.Interstitial lung disease in connective tissue disorders.Lancet,2012,380(9842):689-698.
[2]Vij R,Strek ME.Diagnosis and treatment of connective tissue diseaseassociated interstitial lung disease.Chest,2013,143(3):814-824.
[3]Fischer A,Antoniou KM,Brown KK,et al.An official European Respiratory Society/American Thoracic Society research statement:interstitial pneumonia with autoimmune features.Eur Respir J,2015,46(4):976-987.
[4]Reynolds HY.Use of bronchoalveolar lavage in humanspast necessity and future imperative.Lung,2000,178(5):271-293.
[5]Ammaiyappa C,Ranganathan D,Madhavan J.Bronchoalveolar lavage cellular analyses in conjunction with high resolution computed tomography imaging as a diagnostic intervention for patients with suspected interstitial lung disease.Lung India,2016,33(3):287-291.
[6]Shiboski SC,Shiboski CH,Criswell LA,et al.American College of Rheumatology classification criteria for Sjgren’s syndrome:a datadriven,expert consensus approach in the Sjgren’s International Collaborative Clinical Alliance Cohort.Arthritis Care Res (Hoboken),2012,64(4):475-487.
[7]Aletaha D,Neogi T,Silman AJ,et al.2010 rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Arthritis Rheum,2010,62(9):2569-2581.
[8]Bohan A,Peter JB.Polymyositis and dermatomyositis.N Engl J Med,1975,292(7):344-347.
[9]van den Hoogen F,Khanna D,Fransen J,et al.2013 classification criteria for systemic sclerosis:an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Ann Rheum Dis,2013,72(11):1747-1755.
[10]Meyer KC,Raghu G,Baughman RP,et al.An official American Thoracic Society clinical practice guideline:the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.Am J Respir Crit Care Med,2012,185(9):1004-1014.
[11]Chen X,Cyclin G.A regulator of the p53Mdm2 network.Dev Cell,2002,2(5):518-519.
[12]Marie I,Hachulla E,Cherin P,et al.Interstitial lung disease in polymyositis and dermatomyositis.Arthritis Rheum,2002,47(6):614-622.
[13]Sugiura Y,Banno S,Matsumoto Y,et al.Transforming growth factor betal gene polymorphism in patients with systemic sclerosis.J Rheumatol,2003,30(7):1520-1523.
[14]赛晓焱,蔡后荣.具有自身免疫特征的间质性肺炎研究进展.中国呼吸与危重监护杂志,2017,16(3):300-304.
[15]Otylia KB,Krzysztof K,Highland KB,et al.Bronchoalvelar lavage fluid in scleroderma interstitial lung disease:technical aspects and clinical correlations:review of the literature.Semin Arthritis Rheum,2010,40(1):73-88.
[16]Strange C,Bolster MB,Roth MD,et al.Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.Am J Respir Crit Care Med,2008,177(1):91-98.
[17]Biederer J,Schnabel A,Muhle C,et al.Correlation between HRCT findings,pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis.Eur Radiol,2004,14(2):272-280.
[18]Fujisawa T,Suda T,Nakamura Y,et al.Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.J Rheumatol,2005,32(1):58-64.
[19]Ito I,Nagai S,Kitaichi M,et al.Pulmonary manifestations of primary Sjogren’s syndrome: a clinical,radiologic and pathologic study.Am J Respir Crit Care Med,2005,171(6):632-638.